文献速递胸部CT

CO-RADS:疑似COVID-19患者的CT分类评估方案——定义与评估

CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation.
PubMed 文献 · Radiology · 2020-04-27

荷兰放射学会基于类似Lung-RADS和BI-RADS的标准化思路制定CO-RADS,用于平扫胸部CT对COVID-19肺部受累的标准化评估。105例临床疑似COVID-19住院患者的平扫胸部CT由8名观察者评估,CO-RADS预测RT-PCR结果的AUC为0.91,预测临床诊断的AUC为0.95,观察者间一致性Fleiss κ为0.47。

要点

  • CO-RADS将COVID-19肺部受累怀疑程度分为1(极低)至5(极高),适用于中重度症状患者。
  • 8名观察者间Fleiss κ为0.47,类别1和5的κ最高(分别为0.58和0.68)。
  • CO-RADS预测RT-PCR的AUC为0.91,预测临床诊断的AUC为0.95。

关键影像表现/征象

  • CO-RADS将平扫胸部CT上COVID-19肺部受累的怀疑程度按1(极低)至5(极高)分级评估。

诊断标准与关键数值

  • CO-RADS分级为1(极低)至5(极高),用于中重度COVID-19症状患者。
  • 观察者间绝对一致573/840次观察(68.2%),Fleiss κ为0.47(95%CI:0.45,0.47)。
  • 类别1的κ为0.58(95%CI:0.54,0.62),类别5的κ为0.68(95%CI:0.65,0.72)。
  • 预测RT-PCR结果的平均AUC为0.91(95%CI:0.85,0.97),预测临床诊断的平均AUC为0.95(95%CI:0.91,0.99)。
  • CO-RADS 1的假阴性率为9/161例(5.6%;95%CI:1.0%,10%),CO-RADS 5的假阳性率为1/286(0.3%;95%CI:0%,1.0%)。

临床应用与阅片要点

  • CO-RADS可用于平扫胸部CT对中重度症状患者COVID-19肺部受累的标准化评估。
  • 类别1和5的观察者间一致性最高,类别1假阴性率5.6%,类别5假阳性率0.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background A categorical CT assessment scheme for suspicion of pulmonary involvement of coronavirus disease 2019 (COVID-19 provides a basis for gathering scientific evidence and improved communication with referring physicians. Purpose To introduce the COVID-19 Reporting and Data System (CO-RADS) for use in the standardized assessment of pulmonary involvement of COVID-19 on unenhanced chest CT images and to report its initial interobserver agreement and performance. Materials and Methods The Dutch Radiological Society developed CO-RADS based on other efforts for standardization, such as the Lung Imaging Reporting and Data System or Breast Imaging Reporting and Data System. CO-RADS assesses the suspicion for pulmonary involvement of COVID-19 on a scale from 1 (very low) to 5 (very high). The system is meant to be used in patients with moderate to severe symptoms of COVID-19. The system was evaluated by using 105 chest CT scans of patients admitted to the hospital with clinical suspicion of COVID-19 and in whom reverse transcription-polymerase chain reaction (RT-PCR) was performed (mean, 62 years ± 16 [standard deviation]; 61 men, 53 with positive RT-PCR results). Eight observers used CO-RADS to assess the scans. Fleiss κ value was calculated, and scores of individual observers were compared with the median of the remaining seven observers. The resulting area under the receiver operating characteristics curve (AUC) was compared with results from RT-PCR and clinical diagnosis of COVID-19. Results There was absolute agreement among observers in 573 (68.2%) of 840 observations. Fleiss κ value was 0.47 (95% confidence interval [CI]: 0.45, 0.47), with the highest κ value for CO-RADS categories 1 (0.58, 95% CI: 0.54, 0.62) and 5 (0.68, 95% CI: 0.65, 0.72). The average AUC was 0.91 (95% CI: 0.85, 0.97) for predicting RT-PCR outcome and 0.95 (95% CI: 0.91, 0.99) for clinical diagnosis. The false-negative rate for CO-RADS 1 was nine of 161 cases (5.6%; 95% CI: 1.0%, 10%), and the false-positive rate for CO-RADS category 5 was one of 286 (0.3%; 95% CI: 0%, 1.0%). Conclusion The coronavirus disease 2019 (COVID-19) Reporting and Data System (CO-RADS) is a categorical assessment scheme for pulmonary involvement of COVID-19 at unenhanced chest CT that performs very well in predicting COVID-19 in patients with moderate to severe symptoms and has substantial interobserver agreement, especially for categories 1 and 5. © RSNA, 2020 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Prokop M, van Everdingen W, van Rees Vellinga T, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020. PMID: 32339082. doi:10.1148/radiol.2020201473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。